Nivalis Therapeutics (NASDAQ: NVLS) filed a IPO on form S-1 with the SEC. The company plans to offer up to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE